Vaccine news! More than 94percent safe and efficient, the company soared 65 billion

category:Finance
 Vaccine news! More than 94percent safe and efficient, the company soared 65 billion


Apply to FDA for emergency use authorization

On Monday (November 30, Eastern time), Moderna updated the data of the new crown vaccine, confirming that the vaccine was safe and effective by more than 94%.

The latest efficacy analysis of Moderna evaluated 30000 subjects in phase III clinical trial, half of whom received vaccine and half received placebo, resulting in 196 confirmed cases. Among them, 185 cases were observed in placebo group and 11 cases were observed in vaccine group. The vaccine effective rate was 94.1%.

However, there was no severe case in the vaccinated group. All 30 severe patients were in the placebo group, and there was one death case in the placebo group.

At the same time, the vaccine is also well tolerated without serious adverse events. The most common side effects are fatigue, muscle pain, headache and injection site pain. In addition, the effect of the vaccine on different age, race and gender was consistent. 196 confirmed cases included 33 adults over the age of 65 and 42 ethnic minorities.

Moderna said the full trial data has not yet been released, but will be published in peer-reviewed journals in due course.

Moderna published the first interim efficacy analysis of phase III clinical trial on November 16. Based on 95 confirmed cases, 90 cases were observed in placebo group and 5 cases were observed in mrna-1273 group. The vaccine efficiency was 94.5%.

Moderna is submitting data to regulators in the United States, Europe and the UK for emergency permission. It plans to apply to the FDA for emergency use authorization on Monday.

So far, Moderna has become the second pharmaceutical manufacturer to apply to FDA. Previously, Pfizer had applied for emergency use authorization on November 20.

The FDA plans to meet with the Advisory Committee on vaccines and related biological products on December 10 to review Pfizers application, and to review the application with Moderna on December 17.

Alex Azar, the U.S. Secretary of health and human services, said the FDA would take action as soon as possible to approve Pfizer and Moderna vaccines for emergency use, with about 40 million doses available by the end of this year.

Seven million doses of vaccine have been purchased in the UK

The UK has purchased 7 million doses of vaccine, 5 million on the day Moderna announced a 94.5% interim result, and another 2 million last week. But the vaccine is not expected to be available to the UK until March. Moderna, which is headquartered in Massachusetts, has received US $2.48 billion in federal funds, which is an important part of Trumps operation twist.

Moderna became the third company after Pfizer and Oxford / AstraZeneca to pass its data to regulatory approval. Vaccines in the UK are generally 70 per cent effective, although they have unexpectedly increased to 90 per cent in a group of volunteers receiving lower doses. The findings will now be tested in the United States because of concerns that it may be related to younger volunteers (under 55).

CCTV news reports novel coronavirus pneumonia cases in the United States reached 13343698 on November 29th at 17:05 a.m. Eastern time, and 266642 cases died in total, according to statistics from Johns Hopkins University. In the past 24 hours, 114182 new confirmed cases and 704 new deaths have been reported in the United States.

Novel coronavirus pneumonia confirmed in 15871 cases in 24 hours, and 1605172 cases were confirmed in November 28th. 479 cases of newly diagnosed 28 days died and 58030 cases died. According to statistics, the total number of new confirmed cases in the past seven days decreased by 35955 cases, a decrease of 24.1%; however, in the past seven days, there were 3406 new deaths, a significant increase of 545 cases over the previous seven days, with an increase of 19%.

Biden named former Federal Reserve Chairman Janet Yellen as treasury secretary. According to Reuters news agency, Biden announced the nomination of former Federal Reserve Chairman Janet Yellen as treasury secretary. If confirmed, Yellen will also become the first female Treasury Secretary in the United States. According to the associated press, Yellen, 74, is widely praised in the financial sector and will become the first woman to head the Treasury if formally appointed. Fox News said Yellen had been in the democratic government for a long time and was the first woman to run the Federal Reserve. He was appointed chairman of the Federal Reserve by Obama to help steer the U.S. economy out of the 2008 financial crisis. According to the report, Yellen had previously served as the chairman of the economic advisory board of the former President Clinton administration. Source: Chen Hequn, editor in charge of China fund daily_ NB12679

Biden appointed former Fed chairman Yellen as treasury secretary

According to Reuters news agency, Biden announced the nomination of former Federal Reserve Chairman Janet Yellen as treasury secretary. If confirmed, Yellen will also become the first female Treasury Secretary in the United States.

According to the associated press, Yellen, 74, is widely praised in the financial sector and will become the first woman to head the Treasury if formally appointed. Fox News said Yellen had been in the democratic government for a long time and was the first woman to run the Federal Reserve. He was appointed chairman of the Federal Reserve by Obama to help steer the U.S. economy out of the 2008 financial crisis. According to the report, Yellen had previously served as the chairman of the economic advisory board of the former President Clinton administration.